📰 Nyse Dyn News
Nyse Dyn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nyse Dyn. Real-time updates on events, politics, business and more.
January 9, 2024
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) shares rose 5.9% during mid-day trading on Tuesday . The company traded as high as $19.57 and last traded at $19.09. Approximately 990,808 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 8,243,103 shares. The stock had previously closed at […]
December 5, 2023
StockNews.com upgraded shares of Dyne Therapeutics (NYSE:DYN – Free Report) to a sell rating in a report published on Friday morning. Several other research analysts have also commented on DYN. Chardan Capital reiterated a buy rating and set a $20.00 price objective on shares of Dyne Therapeutics in a research note on Friday, August 4th. […]
November 1, 2023
Dyne Therapeutics (NYSE:DYN – Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.99) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.83) by ($0.16), MarketWatch Earnings reports. Dyne Therapeutics Price Performance Shares of NYSE DYN opened at $7.05 on Wednesday. The stock’s 50-day simple moving average is […]
October 2, 2023
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $8.96, but opened at $9.20. Dyne Therapeutics shares last traded at $8.88, with a volume of 4,391 shares traded. Wall Street Analyst Weigh In Several analysts recently weighed in on DYN […]
September 22, 2023
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) insider Richard William Scalzo sold 1,290 shares of the business’s stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $9.41, for a total value of $12,138.90. Following the completion of the sale, the insider now owns 40,795 shares in […]
September 21, 2023
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report) COO Susanna Gatti High sold 2,672 shares of the stock in a transaction on Monday, September 18th. The shares were sold at an average price of $9.41, for a total value of $25,143.52. Following the sale, the chief operating officer now owns 104,544 shares in the company, […]
September 14, 2023
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report)’s stock price fell 4.9% during mid-day trading on Tuesday . The company traded as low as $10.57 and last traded at $10.63. 109,388 shares were traded during mid-day trading, a decline of 73% from the average session volume of 404,265 shares. The stock had previously closed at […]
September 14, 2023
Dyne Therapeutics, Inc. (NYSE:DYN – Get Free Report)’s stock price traded down 4.9% during trading on Tuesday . The company traded as low as $10.57 and last traded at $10.63. 109,388 shares changed hands during trading, a decline of 73% from the average session volume of 404,265 shares. The stock had previously closed at $11.18. […]
September 11, 2023
Logos Global Management LP reduced its holdings in Dyne Therapeutics, Inc. (NYSE:DYN – Free Report) by 20.9% during the 1st quarter, Holdings Channel reports. The fund owned 1,700,000 shares of the company’s stock after selling 450,000 shares during the period. Dyne Therapeutics makes up about 2.8% of Logos Global Management LP’s holdings, making the stock […]
August 18, 2023
StockNews.com initiated coverage on shares of Dyne Therapeutics (NYSE:DYN – Free Report) in a report released on Thursday morning. The firm issued a sell rating on the stock. Several other brokerages also recently weighed in on DYN. Chardan Capital restated a buy rating and set a $20.00 price objective on shares of Dyne Therapeutics in […]